
-
2014
Company Description
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Eligobiotics, a new generation of antimicrobials that can be programmed to target bacteria based on their genome. Eligobiotics therefore provide a new approach to explore, understand and control bacterial ecosystems both in human and animals. They can notably be used to selectively eradicate harmful pathogens from the microbiome while sparing beneficial ones.
-
Manufacturer:
Science and Engineering -
Formed:
2014 -
Founders:
David Bikard -
Company Website:
-
Company E-mail:
-
Company Address:
ParisFrance -
CEO:
- David Bikard
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits